Get started
Organovo Holdings, Inc.Organovo Holdings, Inc.Organovo Holdings, Inc.

Organovo Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ONVO chart


Full chart

ONVO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.15 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.3837 USD
Net income (FY)
‪−14.67 M‬ USD
Revenue (FY)
‪109.00 K‬ USD
Shares float
‪15.07 M‬
Beta (1Y)
−0.16

Employees


Employees (FY)
20
Change (1Y)
−4 −16.67%
Revenue / Employee (1Y)
‪5.45 K‬ USD
Net income / Employee (1Y)
‪−733.55 K‬ USD

About Organovo Holdings, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Keith Murphy
Website
organovo.com
Headquarters
San Diego
Founded
2012
FIGI
BBG001M8GFD0
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ONVO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ONVO is 0.4430 USD — it has decreased by −4.73% in the past 24 hours. Watch Organovo Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Organovo Holdings, Inc. stocks are traded under the ticker ONVO.
ONVO stock has risen by 0.68% compared to the previous week, the month change is a −6.93% fall, over the last year Organovo Holdings, Inc. has showed a −68.80% decrease.
We've gathered analysts' opinions on Organovo Holdings, Inc. future price: according to them, ONVO price has a max estimate of 6.10 USD and a min estimate of 6.10 USD. Watch ONVO chart and read a more detailed Organovo Holdings, Inc. stock forecast: see what analysts think of Organovo Holdings, Inc. and suggest that you do with its stocks.
ONVO reached its all-time high on Nov 18, 2013 with the price of 273.0000 USD, and its all-time low was 0.4010 USD and was reached on Oct 28, 2024. View more price dynamics on ONVO chart.
See other stocks reaching their highest and lowest prices.
ONVO stock is 6.90% volatile and has beta coefficient of −0.16. Track Organovo Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Organovo Holdings, Inc. there?
Today Organovo Holdings, Inc. has the market capitalization of ‪6.81 M‬, it has decreased by −3.97% over the last week.
Yes, you can track Organovo Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Organovo Holdings, Inc. is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ONVO earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.23 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.26 USD per share. See more details about Organovo Holdings, Inc. earnings.
Organovo Holdings, Inc. revenue for the last quarter amounts to ‪39.00 K‬ USD, despite the estimated figure of ‪39.00 K‬ USD. In the next quarter, revenue is expected to reach ‪41.00 K‬ USD.
ONVO net income for the last quarter is ‪−3.34 M‬ USD, while the quarter before that showed ‪−3.04 M‬ USD of net income which accounts for −9.82% change. Track more Organovo Holdings, Inc. financial stats to get the full picture.
No, ONVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 20.00 employees. See our rating of the largest employees — is Organovo Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organovo Holdings, Inc. EBITDA is ‪−13.99 M‬ USD, and current EBITDA margin is ‪−13.58 K‬%. See more stats in Organovo Holdings, Inc. financial statements.
Like other stocks, ONVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organovo Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Organovo Holdings, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Organovo Holdings, Inc. stock shows the sell signal. See more of Organovo Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.